Recent highlights and breakthroughs in immunotherapy for head and neck cancers

Current Opinion in Oncology · Published 2026-03-05 · DOI 10.1097/cco.0000000000001211

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1097/cco.0000000000001211

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• FGF/FGFR Alteration Type as a Candidate Enrichment Biomarker for Gunagratinib in Recurrent or Metastatic Head and Neck Cancer: An Exploratory Analysis of Two Early-Phase Trials · Targeted Oncology · 2026 · Cites or is cited by this article
• State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma · Current Opinion in Oncology · 2025 · Same journal
• High-risk smoldering myeloma – a case for early intervention? · Current Opinion in Oncology · 2025 · Same journal
• Artificial intelligence for systemic therapy selection and prediction of outcomes in advanced gynecological cancers · Current Opinion in Oncology · 2026 · Same journal
• Curative strategies for high-risk acute promyelocytic leukemia · Current Opinion in Oncology · 2025 · Same journal
• The evolving landscape of bispecific antibodies in the treatment of lung cancer · Current Opinion in Oncology · 2025 · Same journal
• Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma · Current Opinion in Oncology · 2026 · Same journal
• Immunotherapy in rare histologies of breast cancer: challenges, opportunities, and future perspectives · Current Opinion in Oncology · 2025 · Same journal
• Emerging role of functional imaging in renal cell carcinoma: from morphology to molecular phenotyping with PET/computed tomography · Current Opinion in Oncology · 2026 · Same journal
• Desmoplastic small round cell tumor · Current Opinion in Oncology · 2026 · Same journal